Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Triple-Target Stereotactic Radiosurgery for Refractory Mixed Cancer Pain: A Sham-Controlled Pilot Randomized Controlled Trial

NCT07871123 is registered in ClinicalTrials.gov with Centro Internacional del Cáncer as lead sponsor.

NCT NCT07871123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07871123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Triple-Target Stereotactic Radiosurgery for Refractory Mixed Cancer Pain: A Sham-Controlled Pilot Randomized Controlled Trial
Lead sponsor
Centro Internacional del Cáncer
Phase
Not applicable
Overall status
Terminated
Start date
April 1, 2024
Completion date
June 1, 2025
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer pain, refractory pain